** Shares of health insurer Elevance ELV.N rise 4% to $368.49 premarket
** Co reports Q3 adj. profit of $6.03/shr vs. analysts' average estimate of $4.93/shr - LSEG data
** Co's quarterly revenue of $50.1 billion beats analysts' average expectation of $49.37 billion
** ELV reports Q3 medical loss ratio, which is the percentage of premium spent on medical care, of 91.3% vs estimates of 91.73%
** Up to last close, stock down 4% YTD